De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling (original) (raw)
- Letter
- Published: 18 July 2004
- Karen M. O'Rourke1,
- Honglin Zhou1,
- Michael Eby2,
- L. Aravind5,
- Somasekar Seshagiri2,
- Ping Wu3,
- Christian Wiesmann3,
- Rohan Baker6,
- David L. Boone7,
- Averil Ma7,
- Eugene V. Koonin5 &
- …
- Vishva M. Dixit1
Nature volume 430, pages 694–699 (2004)Cite this article
- 15k Accesses
- 1523 Citations
- 11 Altmetric
- Metrics details
Abstract
NF-κB transcription factors mediate the effects of pro-inflammatory cytokines such as tumour necrosis factor-α and interleukin-1β1. Failure to downregulate NF-κB transcriptional activity results in chronic inflammation and cell death, as observed in _A20_-deficient mice2. A20 is a potent inhibitor of NF-κB signalling, but its mechanism of action is unknown2. Here we show that A20 downregulates NF-κB signalling through the cooperative activity of its two ubiquitin-editing domains. The amino-terminal domain of A20, which is a de-ubiquitinating (DUB) enzyme of the OTU (ovarian tumour) family3, removes lysine-63 (K63)-linked ubiquitin chains from receptor interacting protein (RIP), an essential mediator of the proximal TNF receptor 1 (TNFR1) signalling complex4,5. The carboxy-terminal domain of A20, composed of seven C2/C2 zinc fingers6, then functions as a ubiquitin ligase by polyubiquitinating RIP with K48-linked ubiquitin chains, thereby targeting RIP for proteasomal degradation. Here we define a novel ubiquitin ligase domain and identify two sequential mechanisms by which A20 downregulates NF-κB signalling. We also provide an example of a protein containing separate ubiquitin ligase and DUB domains, both of which participate in mediating a distinct regulatory effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Dixit, V. & Mak, T. W. NF-kappaB signaling. Many roads lead to Madrid. Cell 111, 615–619 (2002)
Article CAS Google Scholar - Lee, E. G. et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350–2354 (2000)
Article ADS CAS Google Scholar - Makarova, K. S., Aravind, L. & Koonin, E. V. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem. Sci. 25, 50–52 (2000)
Article CAS Google Scholar - Ting, A. T., Pimentel-Muinos, F. X. & Seed, B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15, 6189–6196 (1996)
Article CAS Google Scholar - Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297–303 (1998)
Article CAS Google Scholar - Opipari, A. W. Jr, Boguski, M. S. & Dixit, V. M. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J. Biol. Chem. 265, 14705–14708 (1990)
CAS PubMed Google Scholar - Aravind, L., Dixit, V. M. & Koonin, E. V. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291, 1279–1284 (2001)
Article ADS CAS Google Scholar - Pickart, C. M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503–533 (2001)
Article CAS Google Scholar - Weissman, A. M. Themes and variations on ubiquitylation. Nature Rev. Mol. Cell Biol. 2, 169–178 (2001)
Article CAS Google Scholar - Yeh, W. C. et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715–725 (1997)
Article CAS Google Scholar - Lee, S. Y. et al. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7, 703–713 (1997)
Article CAS Google Scholar - Kieser, A., Kaiser, C. & Hammerschmidt, W. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2. EMBO J. 18, 2511–2521 (1999)
Article CAS Google Scholar - Tada, K. et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J. Biol. Chem. 276, 36530–36534 (2001)
Article CAS Google Scholar - Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387–396 (1996)
Article CAS Google Scholar - Zhang, S. Q., Kovalenko, A., Cantarella, G. & Wallach, D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12, 301–311 (2000)
Article CAS Google Scholar - Legler, D. F., Micheau, O., Doucey, M. A., Tschopp, J. & Bron, C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18, 655–664 (2003)
Article CAS Google Scholar - Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003)
Article CAS Google Scholar - Balakirev, M. Y., Tcherniuk, S. O., Jaquinod, M. & Chroboczek, J. Otubains: a new family of cysteine proteases in the ubiquitin pathway. EMBO Rep. 4, 517–522 (2003)
Article CAS Google Scholar - Borodovsky, A. et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 9, 1149–1159 (2002)
Article CAS Google Scholar - Evans, P. C. et al. A novel type of deubiquitinating enzyme. J. Biol. Chem. 278, 23180–23186 (2003)
Article CAS Google Scholar - Evans, P. C. et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378, 727–734 (2004)
Article CAS Google Scholar - Deng, L. et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361 (2000)
Article CAS Google Scholar - Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001)
Article ADS CAS Google Scholar - Shi, C. S. & Kehrl, J. H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278, 15429–15434 (2003)
Article CAS Google Scholar - Wilkinson, K. D. Signal transduction: aspirin, ubiquitin and cancer. Nature 424, 738–739 (2003)
Article ADS CAS Google Scholar - Zhou, H. et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427, 167–171 (2004)
Article ADS CAS Google Scholar - Hsu, H., Shu, H. B., Pan, M. G. & Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299–308 (1996)
Article CAS Google Scholar - Devin, A. et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419–429 (2000)
Article CAS Google Scholar - Poyet, J. L. et al. Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization. J. Biol. Chem. 275, 37966–37977 (2000)
Article CAS Google Scholar - Devin, A. et al. The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell. Biol. 21, 3986–3994 (2001)
Article CAS Google Scholar
Acknowledgements
The authors would like to thank R. Deshaies, T. Mayor, R. Feldman and members of the Dixit Lab for helpful discussions, T. Mayor and M. Petroski for reagents, D. Yansura for technical assistance, and K. Newton for editorial assistance. We acknowledge the contributions from colleagues whose work has been cited indirectly owing to space limitations. I.E.W. was supported in part by a PSTP fellowship from the University of California at Davis.
Author information
Authors and Affiliations
- Department of Molecular Oncology, Genentech Inc., South San Francisco, California, 94080, USA
Ingrid E. Wertz, Karen M. O'Rourke, Honglin Zhou & Vishva M. Dixit - Department of Molecular Biology, Genentech Inc., South San Francisco, California, 94080, USA
Michael Eby & Somasekar Seshagiri - Department of Protein Engineering, Genentech Inc., South San Francisco, California, 94080, USA
Ping Wu & Christian Wiesmann - Department of Biological Chemistry, School of Medicine, University of California, Davis, Davis, California, 95616, USA
Ingrid E. Wertz - Computational Biology Branch, NCBI, NLM, NIH, Bethesda, Maryland, 20894, USA
L. Aravind & Eugene V. Koonin - Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, 2601, Australia
Rohan Baker - Department of Medicine, University of California, San Francisco, San Francisco, California, 94143, USA
David L. Boone & Averil Ma
Authors
- Ingrid E. Wertz
You can also search for this author inPubMed Google Scholar - Karen M. O'Rourke
You can also search for this author inPubMed Google Scholar - Honglin Zhou
You can also search for this author inPubMed Google Scholar - Michael Eby
You can also search for this author inPubMed Google Scholar - L. Aravind
You can also search for this author inPubMed Google Scholar - Somasekar Seshagiri
You can also search for this author inPubMed Google Scholar - Ping Wu
You can also search for this author inPubMed Google Scholar - Christian Wiesmann
You can also search for this author inPubMed Google Scholar - Rohan Baker
You can also search for this author inPubMed Google Scholar - David L. Boone
You can also search for this author inPubMed Google Scholar - Averil Ma
You can also search for this author inPubMed Google Scholar - Eugene V. Koonin
You can also search for this author inPubMed Google Scholar - Vishva M. Dixit
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toVishva M. Dixit.
Ethics declarations
Competing interests
The authors declare that they have no competing financial interests.
Supplementary information
Supplementary Information
This document contains supplementary methods, supplementary figures 1-7 and supplementary references. (DOC 1395 kb)
Rights and permissions
About this article
Cite this article
Wertz, I., O'Rourke, K., Zhou, H. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling.Nature 430, 694–699 (2004). https://doi.org/10.1038/nature02794
- Received: 22 April 2004
- Accepted: 29 June 2004
- Published: 18 July 2004
- Issue Date: 05 August 2004
- DOI: https://doi.org/10.1038/nature02794